Manulife (Manufacturers Life Insurance)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
JGGDR
WBG
Manulife (Manufacturers Life Insurance)'s XPH Position: Q2 2018 in Review
Manulife (Manufacturers Life Insurance) sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2018, closing a stake of 564 shares — an estimated $24K sold.
Manulife (Manufacturers Life Insurance) first reported a position in XPH in Q1 2015 and held it in 13 quarters. The position peaked at $124K in Q3 2016. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.
- Manulife (Manufacturers Life Insurance) reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 564 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2018, an estimated $24K.
- Manulife (Manufacturers Life Insurance) first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2015 and held it in 13 quarters.
- Manulife (Manufacturers Life Insurance)'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $124K in Q3 2016.
- 70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2018, filed 14 Aug 2018.